Skip to main
ALQA
ALQA logo

Alliqua BioMedical (ALQA)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Alliqua BioMedical (ALQA) Stock

About Alliqua BioMedical (ALQA)

Adynxx, Inc. is a clinical stage biopharmaceutical company, which engages in the manufacture, development, and sale of novel, disease-modifying products for the treatment of pain and inflammation. The company was founded by Julien Mamet in 2007 and is headquartered in San Francisco, CA.
Market cap
Today's volume
Revenue (TTM)
Avg. daily volume287.8
EBITDA (TTM)
Open
Price / earnings ratio
Today's range
Debt / equity
52 week range
5 year debt / equity
Beta (LTM)15.88x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earnings
Dividend payable date

Frequently Asked Questions (FAQ)

The 52-week high for ALQA stock is $0.00. The current ALQA stock price $undefined is 100.00% below its 52-week high

No, the ALQA stock does not pay dividends to its shareholders

How to buy ALQA stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in ALQA stock

    Navigate to the Explore page. Then, type ALQA into the search bar. When you see ALQA stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased ALQA stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Buy Alliqua BioMedical (ALQA) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.